Friedman Billings Adds Pharmion (PHRM) a biotech Top Pick
More News related to PHRM
- Pharmion (PHRM) Shareholders Approve Acquisition by Celgene (CELG)
- Cohen's SAC Capital Moves Out of Pharmion (PHRM)
- Cohen's SAC Capital Wants A Higher Bid for Pharmion (PHRM)
- Cohen's SAC Capital Boosts Stake in Pharmion (PHRM) to 8.3%
- Cohen's SAC Capital Discloses 7% Stake in Merger Stock Pharmion (PHRM)
More News related to Analyst Comments
- Goldman Sachs Added Cytec Industries (CYT) to their Conviction Sell List
- FBR Capital Recommends An IPO or Spin Off at Chesapeake Energy (CHK)
- Canaccord Adams Maintains a 'Buy' on Silver Wheaton (SLW); Raises Price Target
- Citi Boosts Target on McDonald's (MCD) to $64, Maintains Hold
- Canaccord Adams Reiterates a 'Buy' on Veeco Instruments (VECO); Raises PT & Estimates
CONTRIBUTOR http://notablecalls.blogspot.com
FBR notes Pharmion (NASDAQ: PHRM) joins CELG as a biotech Top Pick on the FBR Top Picks list. Firm thinks PHRM should be trading at $32 in the next 12 months, implying 37% appreciation potential. They reach their $32 target by multiplying 2010 EPS estimate of $1.61 by a multiple of 30x and discounting at 20%. Firm's 2010 EPS assumes revenue of $482M, but there could be upside to this number; the company recently guided for revenues to range from $600M to $825M in 2010.
Drivers for outperformance include: further evidence from monthly data that Vidaza can survive - and even grow " with Dacogen now on the market, key presentations at ASH that position Vidaza for further growth, and 1H07 filings in Europe on thalidomide (calling attention to the possibility that approval could double sales from its current run rate of $76 million) and satraplatin in prostate cancer.
Notablecalls: Expect to see some mild buy interest following the call.
http://notablecalls.blogspot.com
Related Categories
Analyst CommentsContributors
Stocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
